Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada

Journal of Managed Care Pharmacy

Volumn 15, Issue 6, 2009, Pages 476-484

  Evans, Charity D ^a   Eurich, Dean T ^b   Lamb, Darcy A ^a   Taylor, Jeffrey G ^a   Jorgenson, Derek J ^a   Semchuk, William M ^c   Mansell, Kerry D ^a   Blackburn, David F ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c REGINA QU APPELLE HEALTH REGION   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARTICLE; CANADA; CHI SQUARE TEST; CONFOUNDING VARIABLE; CORRELATION COEFFICIENT; DATA BASE; DRUG INDUSTRY; DRUG MARKETING; DRUG UTILIZATION; FOLLOW UP; GOVERNMENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; LOWEST INCOME GROUP; MANAGED CARE; OBSERVATION; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; STATISTICAL SIGNIFICANCE; TABLET;

EID: 69149106819     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2009.15.6.476     Document Type: Article

References (19)

1. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Effectiveness of interventions by community pharmacists to improve patient adherence to chronic medication: a systematic review. Ann Pharmacother. 2005;39(2):319-328
2. Kalsekar I, Sheehan C, Peak A. Utilization patterns and medication adherence in patients with type 2 diabetes: variations based on type of pharmacy (chain vs independent). Research Soc Adm Pharm. 2007;3(4):378-391
3. National Community Pharmacists Association. Independent pharmacies take top honors in Consumer Reports nationwide survey. September 10, 2003. Available at: http://www.ncpanet.org/media/releases/2003/independent-pharmacies-take-top- honors-in-09-10-2003.php. Accessed July 2, 2009.
4. White TJ, Chang E, Leslie S, et al. Patient adherence with HMG reductase inhibitor therapy among users of two types of prescription services. J Manag Care Pharm. 2002;8(3):186-191 Available at: http.//www.amcp org/data/jmcp/ Research-186-191.pdf.
5. World Health Organization. Adherence to long-term therapies: evidence for action. 2003. Available at: http://www.who.int/chp/knowledge/publications/ adherence-full-report.pdf. Accessed July 4, 2009.
6. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15. Available at: http://www.bmj.com/cgi/reprint/333/7557/ 15?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=l&authorl=Simpso n%2C+S&author2=Eurich%2C+D&andorexacttitle=and&andorexacttitleabs =and&andorexactfulltext=and&searchid=l&FIRSTlNDEX=0&sortspec= date &fdate=l/l/1981&resourcetype=HWCIT. Accessed July 2, 2009.
7. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW. Cardiovascular morbidity associated with nonadherence to statin therapy. Pharmacotherapy. , ; 2005;25(8):1035-1043 '
8. Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol. 2003;158(9):915-20. Available at: http://aje.oxford-journals.org/cgi/reprint/158/9/915. Accessed July 4, 2009.
9. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002,288(4):462-67. Available at: http://jama.ama-assn.org/cgi/ j reprint/288/4/462. Accessed July 4, 2009. ' (Pubitemid 34787477)
10. Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol. 2005;21(6):485-488
11. Benner JS, Glynn RJ, Mogun H, Neumann PJ, Weinstein MC, Avorn J. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288(4):455-61. Available at: http://jama.ama-assn.org/cgi/ reprint/288/4/455. Accessed July 4, 2009. (Pubitemid 34787476)
12. Simons LA, Levis G, Simons J. Apparent discontinuation rates in patients prescribed lipid-lowering drugs. Med J Aust. 1996;164(4):208-211 (Pubitemid 26057169)
13. The Pharmacy Group. Community pharmacy in Canada: executive summary. Trends & insights: 2007 survey of pharmacy owners & managers. February 2008. Available at: http://www.mckesson ca/documents/Trends-2007.pdf. Accessed July 4, 2009.
14. Insull W. The problem of compliance to cholesterol altering therapy. J Intern Med. 1997;241(4):317-25. Available at: http://www3.interscience.wiley. com/cgi-bin/fuUtext/119157813/PDFSTART. Accessed July 2, 2009. (Pubitemid 27223997)
15. Larsen J, Andersen M, Kragstrup J, Gram LF. High persistence of statin use in a Danish population: compliance study 1993-1998. Br J Clin Pharmacol. 2002;53(4):375-78. Available at: http://www3.interscience.wiley. com/cgi-bin/fulltext/118951840/PDFSTART. Accessed July 2, 2009.
16. Pedan A, Varasteh LT, Schneeweiss S. Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. J Manag Care Pharm. 2007;13(6):487-496 Available at: http://www.amcp.org/data/jmcp/pages%20 487-96.pdf. (Pubitemid 350193369)
17. Chodick G, Shalev V, Gerber Y, et al. Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel. Clin Ther. 2008;30(ll):2167-2179
18. Vinker S, Shani M, Baevsky T, Elhayany A. Adherence with statins over 8 years in a usual care setting. Am J Manag Care. 2008;14(6):388-92. Available at: http://www.ajmc.com/media/pdf/AJMC-08jun-Vinker388to392.pdf. Accessed July 2, 2009. (Pubitemid 351928444)
19. Grymonpre R, Cheang M, Fraser M, Metge C, Sitar DS. Validity of a prescription claims database to estimate medication adherence in older persons. Med Care. 2006;44(5):471-477